AI-driven approaches in transcription modulator discovery are highlighted, including in silico target identification, multi-omics integration, and structure–activity optimization, and the importance of explainable AI and personalised therapeutics in advancing precision medicine and next-generation transcription-based drug discovery is emphasised.
A. Pimpale, P. Waghmare, Pallavi Zode et al.· Journal of Applied Pharmaceu...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.